BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 21651851)

  • 1. [An experimental study on intestinal epithelial barrier dysfunction induced by interferon-gamma and tumor necrosis factor-alpha].
    Liu H; Wang P; Wang FJ
    Zhonghua Shao Shang Za Zhi; 2011 Apr; 27(2):145-9. PubMed ID: 21651851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of hypoxia-inducible factor-1α by YC-1 attenuates interferon-γ and tumor necrosis factor-α-induced intestinal epithelial barrier dysfunction.
    Liu H; Li M; Wang P; Wang F
    Cytokine; 2011 Dec; 56(3):581-8. PubMed ID: 21890376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amelioration of IFN-γ and TNF-α-induced intestinal epithelial barrier dysfunction by berberine via suppression of MLCK-MLC phosphorylation signaling pathway.
    Cao M; Wang P; Sun C; He W; Wang F
    PLoS One; 2013; 8(5):e61944. PubMed ID: 23671580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of hydrogen sulfide on TNF-α and IFN-γ-induced injury of intestinal epithelial barrier function in Caco-2 monolayers.
    Chen SW; Zhu J; Zuo S; Zhang JL; Chen ZY; Chen GW; Wang X; Pan YS; Liu YC; Wang PY
    Inflamm Res; 2015 Oct; 64(10):789-97. PubMed ID: 26249853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chang'an II Decoction ( II )-Containing Serum Ameliorates Tumor Necrosis Factor-α-Induced Intestinal Epithelial Barrier Dysfunction via MLCK-MLC Signaling Pathway in Rats.
    Chen T; Yin XL; Kang N; Wang XG; Li BS; Ji HJ; Zhang YQ; Bian LQ; Zhang BH; Wang FY; Tang XD
    Chin J Integr Med; 2020 Oct; 26(10):745-753. PubMed ID: 31768870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective role of oligomycin against intestinal epithelial barrier dysfunction caused by IFN-γ and TNF-α.
    Liu H; Wang P; Cao M; Li M; Wang F
    Cell Physiol Biochem; 2012; 29(5-6):799-808. PubMed ID: 22613980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total polysaccharides of the Sijunzi decoction attenuate tumor necrosis factor-α-induced damage to the barrier function of a Caco-2 cell monolayer
    Lu Y; Li L; Zhang JW; Zhong XQ; Wei JA; Han L
    World J Gastroenterol; 2018 Jul; 24(26):2867-2877. PubMed ID: 30018481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFN-gamma-induced TNFR2 expression is required for TNF-dependent intestinal epithelial barrier dysfunction.
    Wang F; Schwarz BT; Graham WV; Wang Y; Su L; Clayburgh DR; Abraham C; Turner JR
    Gastroenterology; 2006 Oct; 131(4):1153-63. PubMed ID: 17030185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rebeccamycin Attenuates TNF-α-Induced Intestinal Epithelial Barrier Dysfunction by Inhibiting Myosin Light Chain Kinase Production.
    Watari A; Sakamoto Y; Hisaie K; Iwamoto K; Fueta M; Yagi K; Kondoh M
    Cell Physiol Biochem; 2017; 41(5):1924-1934. PubMed ID: 28391269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of TNF-{alpha} modulation of Caco-2 intestinal epithelial tight junction barrier: role of myosin light-chain kinase protein expression.
    Ma TY; Boivin MA; Ye D; Pedram A; Said HM
    Am J Physiol Gastrointest Liver Physiol; 2005 Mar; 288(3):G422-30. PubMed ID: 15701621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AGR2 ameliorates tumor necrosis factor-α-induced epithelial barrier dysfunction via suppression of NF-κB p65-mediated MLCK/p-MLC pathway activation.
    Ye X; Sun M
    Int J Mol Med; 2017 May; 39(5):1206-1214. PubMed ID: 28339048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-gamma and tumor necrosis factor-alpha disrupt epithelial barrier function by altering lipid composition in membrane microdomains of tight junction.
    Li Q; Zhang Q; Wang M; Zhao S; Ma J; Luo N; Li N; Li Y; Xu G; Li J
    Clin Immunol; 2008 Jan; 126(1):67-80. PubMed ID: 17964857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myosin light chain kinase mediates intestinal barrier dysfunction via occludin endocytosis during anoxia/reoxygenation injury.
    Jin Y; Blikslager AT
    Am J Physiol Cell Physiol; 2016 Dec; 311(6):C996-C1004. PubMed ID: 27760753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of myosin light chain kinase in intestinal epithelial barrier dysfunction due to hypoxia].
    Wang P; Chen CL; Li M; Wang FJ
    Zhonghua Shao Shang Za Zhi; 2009 Feb; 25(1):57-60. PubMed ID: 19588764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression.
    Wang F; Graham WV; Wang Y; Witkowski ED; Schwarz BT; Turner JR
    Am J Pathol; 2005 Feb; 166(2):409-19. PubMed ID: 15681825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor alpha increases epithelial barrier permeability by disrupting tight junctions in Caco-2 cells.
    Cui W; Li LX; Sun CM; Wen Y; Zhou Y; Dong YL; Liu P
    Braz J Med Biol Res; 2010 Apr; 43(4):330-7. PubMed ID: 20445948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1,25-Dihydroxyvitamin D3 preserves intestinal epithelial barrier function from TNF-α induced injury via suppression of NF-kB p65 mediated MLCK-P-MLC signaling pathway.
    Chen S; Zhu J; Chen G; Zuo S; Zhang J; Chen Z; Wang X; Li J; Liu Y; Wang P
    Biochem Biophys Res Commun; 2015 May; 460(3):873-8. PubMed ID: 25838204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanism of tumor necrosis factor-alpha modulation of intestinal epithelial tight junction barrier.
    Ye D; Ma I; Ma TY
    Am J Physiol Gastrointest Liver Physiol; 2006 Mar; 290(3):G496-504. PubMed ID: 16474009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adalimumab prevents barrier dysfunction and antagonizes distinct effects of TNF-α on tight junction proteins and signaling pathways in intestinal epithelial cells.
    Fischer A; Gluth M; Pape UF; Wiedenmann B; Theuring F; Baumgart DC
    Am J Physiol Gastrointest Liver Physiol; 2013 Jun; 304(11):G970-9. PubMed ID: 23538493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wogonoside alleviates colitis by improving intestinal epithelial barrier function via the MLCK/pMLC2 pathway.
    Huang S; Fu Y; Xu B; Liu C; Wang Q; Luo S; Nong F; Wang X; Huang S; Chen J; Zhou L; Luo X
    Phytomedicine; 2020 Mar; 68():153179. PubMed ID: 32062328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.